[Federal Register Volume 64, Number 103 (Friday, May 28, 1999)]
[Notices]
[Page 29051]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-13592]



[[Page 29051]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Recombinant DNA Advisory Committee; Notice of Meeting

    Pursuant to Pub. L. 92-463, notice is hereby given of a meeting of 
the Recombinant DNA Advisory Committee, Building 31C, 6th Floor, 
Conference Room 10, 9000 Rockville Pike, Bethesda, Maryland 20892, 
starting on June 14, 1999, at approximately 9 a.m., and will recess at 
approximately 5 p.m. The meeting will be open to the public. Agenda 
items will include: (1) Discussion of novel phase 1 gene transfer 
protocol for pediatric retinoblastoma, (2) Food and Drug Administration 
presentation on vector gonadal distribution and inadvertent germ line 
gene transfer, (3) data management activities related to human gene 
transfer clinical trials, and (4) other matters to be considered by the 
Committee. Attendance by the public will be limited to space available.
    Debra W. Knorr, Acting Director, Office of Recombinant DNA 
Activities, National Institutes of Health, MSC 7010, 6000 Executive 
Boulevard, Suite 302, Bethesda, Maryland 20892-7010, Phone (301) 496-
9838, FAX (301) 496-9839, will provide summaries of the meeting and a 
roster of committee members upon request. Individuals who plan to 
attend and need special assistance, such as sign language 
interpretation or other reasonable accommodations, should contact Ms. 
Knorr in advance of the meeting. The Office of Recombinant DNA 
Activities (ORDA) web site is located at http://www.nih.gov/od/orda for 
further information about the office.
    OMB's ``Mandatory Information Requirements for Federal Assistance 
Program Announcements'' (45 FR 39592, June 11, 1980) requires a 
statement concerning the official government programs contained in the 
Catalog of Federal Domestic Assistance. Normally NIH lists in its 
announcements the number and title of affected individual programs for 
the guidance of the public. Because the guidance in this notice covers 
virtually every NIH and Federal research program in which DNA 
recombinant molecule techniques could be used, it has been determined 
not to be cost effective or in the public interest to attempt to list 
these programs. Such a list would likely require several additional 
pages. In addition, NIH could not be certain that every Federal program 
would be included as many Federal agencies, as well as private 
organizations, both national and international, have elected to follow 
the NIH Guidelines. In lieu of the individual program listing, NIH 
invites readers to direct questions to the information address above 
about whether individual programs listed in the Catalog of Federal 
Domestic Assistance are affected.

    Dated: May 20, 1999.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 99-13592 Filed 5-27-99; 8:45 am]
BILLING CODE 4140-01-M